logo
logo
ELV stock ticker logo

Elevance Health, Inc.

NYSE•ELV
CEO: Ms. Gail Koziara Boudreaux
Sector: Healthcare
Industry: Medical - Healthcare Plans
Listing Date: 2001-10-30
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Contact Information
220 Virginia Avenue, Indianapolis, IN, 46204, United States
833-401-1577
www.elevancehealth.com
Market Cap
$62.69B
P/E (TTM)
11.1
25.2
Dividend Yield
2.4%
52W High
$458.75
52W Low
$273.71
52W Range
6%
Rank18Top 5.0%
6.3
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$49.75B+8.51%
4-Quarter Trend

EPS

$2.47+34.24%
4-Quarter Trend

FCF

-$209.00M-154.43%
4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Total Operating Revenue Increased Total operating revenue reached $197.58B USD, marking a 12.8% increase driven by premium yields and acquisitions.
Medicare Revenue Rises Medicare Advantage revenue grew 21.6% to $44.75B USD, reflecting strong membership growth recognition in 2025.
Carelon Services Revenue Surges Carelon Services operating revenue jumped 57.7% to $28.32B USD, fueled by CareBridge acquisition integration.
Membership Mix Shifts Total medical membership fell 1.1% to 45.23M, driven by Medicaid attrition (down 4.7%) partially offset by Individual growth.

Risk Factors

Medicaid Membership Attrition Medicaid membership dropped 4.7% (417K members) due to eligibility redeterminations, impacting Health Benefits segment results.
Shareholders Net Income Down Shareholders' net income decreased 5.3% to $5.66B USD, primarily due to higher medical cost trends in Health Benefits.
Healthcare Cost Prediction Risk Profitability depends on accurately predicting healthcare costs; slight deviations cause significant adverse impact on operations.
Litigation and Regulatory Scrutiny Ongoing BCBSA antitrust litigation and regulatory changes create uncertainty regarding future operations and financial stability.

Outlook

Optimize Core Business Portfolio Expect continued portfolio rationalization, investment in high-growth opportunities, and acceleration of value creation capabilities.
Advance Value-Based Payment Models Actively engaging providers across payment models to align incentives, driving improved quality and better health outcomes.
Public Exchange Policy Influence Future Public Exchange stability depends on federal subsidy policies, compliance requirements, and overall market stability going forward.

Peer Comparison

Revenue (TTM)

CVS stock ticker logoCVS
$402.07B
+7.8%
MCK stock ticker logoMCK
$397.96B
+15.5%
COR stock ticker logoCOR
$325.78B
+7.4%

Gross Margin (Latest Quarter)

REGN stock ticker logoREGN
85.0%
+3.3pp
GSK stock ticker logoGSK
69.4%
+3.5pp
ZTS stock ticker logoZTS
68.9%
+2.4pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
BMY$124.67B17.739.3%52.4%
MCK$122.89B28.3-245.3%10.2%
HCA$121.16B18.4-140.8%82.7%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
0.6%
Moderate Growth
4Q Net Income CAGR
-37.0%
Declining Profitability
Cash Flow Stability
100%
Strong Cash Flow

Deep Research

Next earnings:Apr 20, 2026
|
EPS:-
|
Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement
LTM
No Data